-
- GOLDHABER Samuel Z.
- Cardiovascular Division, Department of Medicine Brigham and Women's Hospital, Harvard Medical School
この論文をさがす
抄録
The epidemiology, diagnosis, treatment, and prophylaxis of PE are rapidly advancing. Our array of diagnostic imaging tools has expanded to include echocardiography and spiral chest CT with contrast. We have also gained a keen appreciation for the importance of risk stratification of our patients. The decision to administer thrombolysis or undertake embolectomy may now depend upon the presence of right ventricular dysfunction even if systemic arterial pressure is normal. Finally, the availability of low molecular weight heparins broadens our options for pharmacologic management.<br>(Internal Medicine 38: 620-625, 1999)
収録刊行物
-
- Internal Medicine
-
Internal Medicine 38 (8), 620-625, 1999
一般社団法人 日本内科学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679843886208
-
- NII論文ID
- 10005529686
-
- NII書誌ID
- AA10827774
-
- COI
- 1:STN:280:DyaK1MzmslWjug%3D%3D
-
- ISSN
- 13497235
- 09182918
-
- NDL書誌ID
- 4806261
-
- PubMed
- 10440496
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可